GE3LS stands for the evaluation of ethical, environmental, economic, legal and social implications of genomics research and development. (While there are three “E”s – ethics, environment and economic– the acronym GE3LS is most often used, rather than GEEELS.) The careful evaluation of genomics aims to optimize the global health and minimize the risks of genomics/biotechnology advances as they occur. This involves anticipating the social implications of these advances. The goal is to develop ethical guidelines for the advancement of genomics research.
The program examines the implications of genomics/biotechnology for one of the greatest ethical challenges in the world today-the enormous disparities in global health. The team members are studying the biotechnology policies of governments in developing countries and examine their ability to exploit new technologies for the health of their population; look at multinational corporations’ decision-making on health-related genomics/ biotechnology; identifying best practices for the introduction of vaccines, nutrients and drugs in plants; and gathering international perspectives on regulating genomics research. The researchers are also examining the impact of genomics on health systems and insurance, and study issues surrounding transgenic animals. The team hopes to develop best practice guidelines for governments, corporations and technology creators.
Additional information can be found at: The Canadian Program on Genomics and Global Health.